US 8906872
Antisense antiviral compound and method for treating ssRNA viral infection
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8906872 (Antisense antiviral compound and method for treating ssRNA viral infection) held by Sarepta Therapeutics, Inc. expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P31/12, A61P31/14